Potential for earlier diagnosis of ovarian cancer
(Medical Xpress) -- Australian scientists have identified biochemical changes that commonly occur in the DNA of women with ovarian cancer, which may help diagnose the cancer at an earlier stage in the future.
Using whole genome DNA profiling methods, Brian Gloss, Dr Philippa OBrien and Professor Susan Clark from Sydneys Garvan Institute of Medical Research have identified a panel of 6 genes that are affected by an epigenetic process known as DNA methylation in ovarian cancer.
The Garvan team collaborated with Professor Neville Hacker, Director Gynaecological Cancer Unit, Royal Hospital for Women Randwick, who provided tumour samples from ovarian cancer patients, as well as tissue samples from normal ovaries.
The findings are published in the journal Cancer Letters, now online.
Ovarian cancer is not easily diagnosed early, and people with advanced disease tend to die quickly.
Women diagnosed at a late stage the majority have a 30% 5-year survival rate. Women diagnosed at an early stage have a 90% 5-year survival rate.
Although ovarian cancer is a relatively rare disease, it is the leading cause of death due to gynaecological cancers, and the sixth leading cause of cancer death in women. Around one in 70 women will develop the cancer, and around one in 100 women will die from it.
Ovarian cancers are usually diagnosed once the disease has spread past the pelvis and into other organs including the stomach, bowel and lungs. They are typically very hard to get rid of with surgery and they tend to become rapidly resistant to chemotherapeutics.
This was one of first studies that used whole genome techniques to directly profile DNA methylation aberrations in ovarian cancer - with the aim of identifying diagnostic biomarkers, said Brian Gloss, who focused on the project for his PhD.
When we started in 2008, most other research groups were investigating single genes known to be methylated in other cancers. We decided to make use of new whole genome technologies using DNA methylation profiling and gene expression profiling.
We wanted to see exactly which methylation changes led directly to aberrant gene silencing. In other words, which methylation changes have a functional role in ovarian cancer.
We did our discovery process in cell lines and then validated our findings in 27 cancers versus 12 normal ovarian tissue samples.
One of the key methylated genes we identified was a novel gene, which had not been identified as being misregulated in any cancer before.
When we then analysed a further 100 tumours, we found that the novel biomarker gene was methylated in 80% of them.
This paper represents the first half of our work. The next step will be to see how our panel of biomarker genes is methylated in a larger cohort of ovarian tumours, and to identify the function of our novel gene.
The most difficult aspect of ovarian cancer is that it is a molecularly heterogeneous disease, meaning that each tumour can be quite different from the next.
We need to show, therefore, that our panel of biomarkers will be a sufficiently rigorous diagnostic tool, able to catch the requisite number of tumours.
More information: www.mendeley.com/r… l-novel-pan/
Provided by Garvan Institute of Medical Research
- Unique genetic marker may improve detection of recurrent ovarian cancer Dec 07, 2011 | not rated yet | 0
- Evolving ovarian cancer cells 'dodge' treatment with chemotherapy Dec 20, 2011 | not rated yet | 0
- New test for ovarian cancer patients Nov 09, 2010 | not rated yet | 0
- Ovarian cancer advances when genes are silenced Dec 13, 2010 | not rated yet | 0
- Pill and pregnancy have biggest effects on ovarian cancer risk Oct 26, 2011 | not rated yet | 0
- Motion perception revisited: High Phi effect challenges established motion perception assumptions Apr 23, 2013 | 3 / 5 (2) | 2
- Anything you can do I can do better: Neuromolecular foundations of the superiority illusion (Update) Apr 02, 2013 | 4.5 / 5 (11) | 5
- The visual system as economist: Neural resource allocation in visual adaptation Mar 30, 2013 | 5 / 5 (2) | 9
- Separate lives: Neuronal and organismal lifespans decoupled Mar 27, 2013 | 4.9 / 5 (8) | 0
- Sizing things up: The evolutionary neurobiology of scale invariance Feb 28, 2013 | 4.8 / 5 (10) | 14
Why is zone 1 in liver more prone to ischemic injury?
May 23, 2013 Hi, Is it because around central vein, there is only deoxygenated blood from the vein where as in the periphery there is hepatic artery. Also why...
How can there be villous adenoma in colon, if there are no villi there
May 22, 2013 As title suggest. Thanks :smile:
How can there be a term called "intestinal metaplasia" of stomach
May 21, 2013 Hello everyone, Ok Stomach's normal epithelium is simple columnar, now in intestinal type of adenocarcinoma of stomach it undergoes "intestinal...
Pressure-volume curve: Elastic Recoil Pressure don't make sense
May 18, 2013 From pressure-volume curve of the lung and chest wall (attached photo), I don't understand why would the elastic recoil pressure of the lung is...
If you became brain-dead, would you want them to pull the plug?
May 17, 2013 I'd want the rest of me to stay alive. Sure it's a lousy way to live but it beats being all-the-way dead. Maybe if I make it 20 years they'll...
MRI bill question
May 15, 2013 Dear PFers, The hospital gave us a $12k bill for one MRI (head with contrast). The people I talked to at the hospital tell me that they do not...
- More from Physics Forums - Medical Sciences
More news stories
The British Menopause Society and Women's Health Concern have today released updated guidelines on Hormone Replacement Therapy (HRT) to provide clarity around the role of HRT, the benefits and the risks. The new guidelines ...
Cancer 2 minutes ago | not rated yet | 0
Breast cancer characterized as "triple negative" carries a poor prognosis, with limited treatment options. In some cases, chemotherapy doesn't kill the cancer cells the way it's supposed to. New research from Western University ...
Cancer 11 hours ago | 5 / 5 (3) | 0
Mayo Clinic researchers have used next generation genomic analysis to determine that some of the more aggressive prostate cancer tumors have similar genetic origins, which may help in predicting cancer progression. The findings ...
Cancer 11 hours ago | not rated yet | 0
Even while being dragged to its destruction inside a cell, a cancer-promoting growth factor receptor fires away, sending signals that thwart the development of tumor-suppressing microRNAs (miRNAs) before it's dissolved, researchers ...
Cancer 12 hours ago | not rated yet | 0 |
Treating pediatric leukemia patients with a liposomal formulation of anthracycline-based chemotherapy at a more intense-than-standard dose during initial treatment may result in high survival rates without causing any added ...
Cancer 16 hours ago | not rated yet | 0
(Medical Xpress)—Regulating the distribution of power in neurons is done by a system that makes the national electric grid look simple by comparison. Each neuron has several thousand mitochondria confined ...
11 hours ago | 4.8 / 5 (6) | 0 |
A brief visual task can predict IQ, according to a new study. This surprisingly simple exercise measures the brain's unconscious ability to filter out visual movement. The study shows that individuals whose ...
16 hours ago | 4.5 / 5 (10) | 1 |
Teams of highly respected Alzheimer's researchers failed to replicate what appeared to be breakthrough results for the treatment of this brain disease when they were published last year in the journal Science.
14 hours ago | 5 / 5 (1) | 2 |
Scientists at the National Institutes of Health report they have discovered in mouse studies that a small molecule released in the spinal cord triggers a process that is later experienced in the brain as ...
14 hours ago | 5 / 5 (2) | 0 |
Little is known about why asthma develops, how it constricts the airway or why response to treatments varies between patients. Now, a team of researchers at Weill Cornell Medical College, Columbia University Medical Center ...
15 hours ago | not rated yet | 0 |
Ethnic background plays a surprisingly large role in how diabetes develops on a cellular level, according to two new studies led by researchers at the Stanford University School of Medicine.
12 hours ago | not rated yet | 0 |